Clinical Research - Investigational Medicinal Product (IMP) Quarantine
Document Purpose
The purpose of this procedure is to ensure that unused or unfit IMP identified by the manufacturer, Investigator, Sponsor or Delegate(s), as requiring quarantine is managed in compliance with NSW Health, SCHN, regulatory and Protocol requirements.